Charles River Laboratories International

CRLNYSE United States Health Care Biotechnology: Commercial Physical & Biological Resarch

Market cap

$13.320 B

$279.01 +0.34%

Close of 21 Sept 2026

Revenue

$4.02B

#778 by revenue

Earnings

-$144.3M

Loss-making

Shares outstanding

47,738,872

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap

All 12 →

#2IncyteINCY$25.3B
#3MedpaceMEDP$17.4B
#4Charles River Laboratories InternationalCRL$13.3B
#5IconICLR$13.0B
#6AbsciABSI$1.69B

What if Charles River Laboratories International were worth as much as…

Open the what-if tool →

Gold $30.3T

$634,159.39

Per share 2,273× higher

Bitcoin $1.72T

$36,025.23

Per share 129× higher

Nvidia $5.48T

$114,788.18

Per share 411× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Charles River Laboratories International are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.